Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Engelhart currently holds 15,673 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Engelhart has been a net seller of BHVN stock. They have purchased $150.1K and sold $9.9M worth of shares.
James Engelhart's most recent insider trade was on Oct 3, 2022, when they sold 15,900 shares at $148.50 per share.
James Engelhart serves as Executive at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have executed 42 insider transactions totaling $10.0M over their tenure at the company.
James Engelhart holds the position of Executive at Biohaven Pharmaceutical Holding Co Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
James Engelhart has shown a selling trading pattern, with $150.1K in total purchases and $9.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James Engelhart was on Dec 10, 2021, when they sold $2.4M worth of BHVN shares. This transaction involved 23,487 shares at $102.70 per share.
James Engelhart currently owns 15,673 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Engelhart's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Engelhart has 42 Form 4 filings on record as an insider at Biohaven Pharmaceutical Holding Co Ltd..
Set alerts for James Engelhart and 40,000+ other insiders.